No Data
No Data
KORU Medical Systems to Report Second Quarter 2024 Financial Results on August 7, 2024
KORU Medical Systems (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume
Craig-Hallum Maintains KORU Medical Systems(KRMD.US) With Buy Rating
Craig-Hallum analyst Chase Knickerbocker maintains $KORU Medical Systems(KRMD.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 42.6% and a total average return of 2
Express News | KORU Medical Systems Receives Regulatory Clearance for Freedomedge® Infusion System in Japan
KORU Medical Systems Receives Regulatory Clearance for FreedomEdge Infusion System in Japan
KORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large
CCORF Maintains KORU Medical Systems(KRMD.US) With Buy Rating, Maintains Target Price $3
CCORF analyst Caitlin Cronin maintains $KORU Medical Systems(KRMD.US)$ with a buy rating, and maintains the target price at $3.According to TipRanks data, the analyst has a success rate of 34.8% and a
Craig-Hallum Maintains KORU Medical Systems(KRMD.US) With Buy Rating, Raises Target Price to $150
Craig-Hallum analyst Chase Knickerbocker maintains $KORU Medical Systems(KRMD.US)$ with a buy rating, and adjusts the target price from $4 to $150.According to TipRanks data, the analyst has a success